trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129[1].
[1]. Jason D. Brubaker, et al. Inhibitors of ret. US20170121312A1.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 5mg | ¥1,170.00 | 现货 | 1 | |
| 10mg | ¥1,665.00 | 现货 | 1 | |
| 50mg | ¥6,165.00 | 现货 | 1 | |
| 100mg | ¥9,720.00 | 现货 | 1 |
















trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129[1].
[1]. Jason D. Brubaker, et al. Inhibitors of ret. US20170121312A1.